Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia

1. Estonian Health Insurance Fund . Available at: https://haigekassa.ee/en. (Accessed October 13, 2021).
Google Scholar2. Cervical cancer screening factsheet Estonia, 2017 . Nordscreen database. Available at: https://nordscreen.org/wp-content/uploads/2017/07/cervix-fact-sheet-estonia-2017.pdf. (Accessed July 1,2021).
Google Scholar3. Cancer Incidence in Five Continents . Available at: https://gco.iarc.fr/databases.php. (Accessed February 14, 2021).
Google Scholar4. Ojamaa, K, Innos, K, Baburin, A, et al. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014. BMC Cancer 2018; 18: 1075. PMID: 30404606; PMCID: PMC6222998.
Google Scholar | Crossref | Medline5. Terviseuuringute ja tervisestatistika andmebaas . VSR12: emakakaelavähi sõeluuringu sihtrühma hõlmatus PAP-testi uuringuga vanuse järgi. Available at: https://statistika.tai.ee/pxweb/et/Andmebaas/Andmebaas__02Haigestumus__07Soeluuringud/VSR12.px/. (Accessed February 14, 2021).
Google Scholar6. Yeh, PT, Kennedy, CE, de Vuyst, H, et al. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Global Health 2019; 4: e001351.
Google Scholar | Crossref | Medline7. Arbyn, M, Smith, SB, Temin, S, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. Br Med J 2018; 363: k4823.
Google Scholar | Crossref | Medline8. Gupta, S, Palmer, C, Bik, EM, et al. Self-Sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health 2018; 6: 77. PMID: 29686981; PMCID: PMC5900042.
Google Scholar | Crossref | Medline9. Morgan, K, Azzani, M, Khaing, SL, et al. Acceptability of women self-sampling versus clinician-collected samples for HPV DNA testing: a systematic review. J Low Genit Tract Dis 2019; 23: 193–199. PMID: 30933030.
Google Scholar | Crossref | Medline10. Wong, EL, Cheung, AW, Wong, AY, et al. Acceptability and feasibility of HPV self-sampling as an alternative primary cervical cancer screening in under-screened population groups: a cross-sectional study. Int J Environ Res Public Health 2020; 17: 6245. PMID: 32867315; PMCID: PMC7503998.
Google Scholar | Crossref11. Racey, CS, Gesink, DC, Burchell, AN, et al. Randomized intervention of self-collected sampling for human papillomavirus testing in under-screened rural women: uptake of screening and acceptability. J Womens Health (Larchmt) 2016; 25: 489–497. Epub 2015 Nov 24. PMID: 26598955.
Google Scholar | Crossref | Medline12. Nishimura, H, Yeh, PT, Oguntade, H, et al. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Health 2021; 6: e003743. doi: 10.1136/bmjgh-2020-003743. PMID: 34011537; PMCID: PMC8137189.
Google Scholar | Crossref | Medline13. Lai, T, Habicht, T, Kahur, K, et al. Estonia: health system review. Health Syst Transit 2013; 15: 1–196.
Google Scholar | Medline14. Sultana, F., Mullins, R., English, DR, et al. Women’s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer 2015; 15: 849
Google Scholar | Crossref | Medline15. Enerly, E, Bonde, J, Schee, K, et al. Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme. PLoS One 2016; 11: 1–14.
Google Scholar | Crossref16. Statistical regions in the European Union and partner countries . NUTS And statistical regions. Eurostat 2021. Available at: https://ec.europa.eu/eurostat/documents/3859598/10967554/KS-GQ-20-092-EN-N.pdf/9d57ae79-3ee7-3c14-da3e-34726da385cf. (Accessed July 2, 2021).
Google Scholar17. Virtanen, A, Nieminen, P, Luostarinen, T, et al. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960–1969. Epub 2011 Jul 13. PMID: 21752985.
Google Scholar | Crossref | Medline | ISI18. Jentschke, M, Chen, K, Arbyn, M, et al. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol 2016; 82: 46–50..
Google Scholar | Crossref | Medline19. Karjalainen, L, Anttila, A, Nieminen, P, et al. Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device. BMC Cancer 2016; 16: 221
Google Scholar | Crossref | Medline20. Cadman, L, Reuter, C, Jitlal, M, et al. A randomized comparison of different vaginal self-sampling devices and urine for human papillomavirus testing-predictors 5.1. Cancer Epidemiol Biomarkers Prev 2021; 30: 661–668. Epub 2021 Jan 29. PMID: 33514604.
Google Scholar | Crossref | Medline21. Ernstson, A, Urdell, A, Forslund, O, et al. Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection. Infect Agents Cancer 2020; 15: 10. https://doi.org/10.1186/s13027-020-00280-0.
Google Scholar | Crossref | Medline22. Anhang, R, Nelson, JA, Telerant, R, et al. Jr. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) 2005; 14: 721–728. PMID: 16232104.
Google Scholar | Crossref | Medline | ISI23. Gök, M, Heideman, DA, van Kemenade, FJ, et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012; 48: 1799–1808. Epub 2011 Dec 13. PMID: 22172570.
Google Scholar | Crossref | Medline | ISI24. Malone, C, Barnabas, RV, Buist, DSM, et al. Cost-effectiveness studies of HPV self-sampling: a systematic review. Prev Med 2020; 132: 105953. Epub 2020 Jan 3. PMID: 31911163; PMCID: PMC7219564.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif